Search all medical codes

Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, direct probe technique

CPT4 code

Name of the Procedure:

Infectious Agent Detection by Nucleic Acid (DNA or RNA); Neisseria gonorrhoeae, Direct Probe Technique

Summary

This procedure involves detecting the genetic material (DNA or RNA) of Neisseria gonorrhoeae, the bacterium that causes gonorrhea, using a specialized probe technique. This method allows for the direct identification of the bacteria from a patient's sample.

Purpose

Medical Condition: Gonorrhea, a sexually transmitted infection Goals: The goal is to accurately and quickly identify the presence of Neisseria gonorrhoeae in order to facilitate prompt treatment and prevent complications or further transmission.

Indications

  • Symptoms such as unusual discharge, pain during urination, or genital sores
  • High-risk sexual activity
  • Follow-up testing post-treatment
  • Screening in pregnant women to prevent neonatal infection

Preparation

  • No fasting required.
  • Patients may be advised to avoid urinating one hour before the sample is collected.
  • Inform the healthcare provider of any current medications or treatments.

Procedure Description

  1. Sample Collection: A healthcare provider collects a sample from the affected area (e.g., urine, swab from the genital area, throat, or rectum).
  2. Laboratory Processing:
    • The sample is processed in a laboratory where the nucleic acids (DNA or RNA) are extracted.
    • A probe containing a sequence of DNA or RNA complementary to the bacterial genetic material is added to the sample.
    • If Neisseria gonorrhoeae DNA or RNA is present, it will bind to the probe, producing a detectable signal.

Tools/Equipment: Swabs, collection containers, nucleic acid extraction kits, probe detection systems Anesthesia/Sedation: Not required

Duration

The sample collection takes a few minutes. Laboratory analysis may take a few hours to a couple of days, depending on the facility.

Setting

  • Outpatient clinic
  • Laboratory

Personnel

  • Nurse or technician for sample collection
  • Laboratory technologist for sample analysis
  • Healthcare provider for diagnosis and treatment discussion

Risks and Complications

  • Minimal risk associated with sample collection
  • Rare complications might include minor discomfort or irritation at the collection site

Benefits

  • Rapid and accurate detection of Neisseria gonorrhoeae
  • Enables prompt and appropriate treatment
  • Reduces the risk of complications and transmission to others

Recovery

  • No recovery time needed post-sample collection
  • Follow healthcare provider’s recommendations for treatment if the test is positive

Alternatives

  • Culture tests: Slower results, involves growing the bacteria in a lab.
  • Rapid antigen tests: Generally less accurate but provide quicker results.
  • Serology tests: Not typically used for active infection detection.

Patient Experience

  • Mild discomfort during sample collection
  • Minimal to no pain
  • Anxiety relief with a prompt and accurate diagnosis
  • If positive, peace of mind with effective treatment options and follow-up care

Medical Policies and Guidelines for Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, direct probe technique

Related policies from health plans

Similar Codes